Spectrum of F8 Genotype and Genetic Impact on Inhibitor Development in Patients with Hemophilia A from Multicenter Cohort Studies (J-HIS) in Japan
暂无分享,去创建一个
A. Shirahata | K. Nogami | M. Taki | M. Shima | K. Fukutake | A. Yoshioka | T. Kojima | K. Shinozawa | K. Yada
[1] D. Hampshire,et al. The European Association for Haemophilia and Allied Disorders (EAHAD) Coagulation Factor Variant Databases: Important resources for haemostasis clinicians and researchers , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.
[2] K. Nogami,et al. Contribution of Factor VIII A2 Domain Residues 400–409 to a Factor X-Interactive Site in the Factor Xase Complex , 2018, Thrombosis and Haemostasis.
[3] F. Rosendaal,et al. Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement , 2018, Journal of thrombosis and haemostasis : JTH.
[4] X. Wu,et al. Spectrum and origin of mutations in sporadic cases of haemophilia A in China , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.
[5] J. Shendure,et al. Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative. , 2017, Blood advances.
[6] Raymond Dalgleish,et al. HGVS Recommendations for the Description of Sequence Variants: 2016 Update , 2016, Human mutation.
[7] K. Nogami,et al. Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti‐C2 antibody inhibiting allogeneic but not autologous factor VIII activity , 2015, Journal of thrombosis and haemostasis : JTH.
[8] D. Middleton,et al. Determination of HLA‐A, ‐C, ‐B, ‐DRB1 allele and haplotype frequency in Japanese population based on family study , 2015, Tissue antigens.
[9] D. Moss,et al. A large‐scale computational study of inhibitor risk in non‐severe haemophilia A , 2015, British journal of haematology.
[10] K. Nogami,et al. The first case of int1h‐related inversion in Japanese haemophilia A patients , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.
[11] K. Nogami,et al. Long-term treatment course of a patient with mild haemophilia A who developed a high titre factor VIII inhibitor , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.
[12] J. Astermark,et al. GENERAL INTRODUCTION AND OUTLINE OF THE THESIS , 2012 .
[13] J. Oldenburg,et al. Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study. , 2013, Blood.
[14] C. Miller,et al. The CDC Hemophilia A Mutation Project (CHAMP) Mutation List: A New Online Resource , 2013, Human mutation.
[15] Y. Kanda,et al. Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.
[16] S. Kim,et al. Mutation spectrum and inhibitor risk in 100 Korean patients with severe haemophilia A , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.
[17] C. Hermans,et al. Computational and molecular approaches for predicting unreported causal missense mutations in Belgian patients with haemophilia A , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.
[18] M. Margaglione,et al. F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis. , 2012, Blood.
[19] P. Fay,et al. Factor VIII light chain contains a binding site for factor X that contributes to the catalytic efficiency of factor Xase. , 2012, Biochemistry.
[20] J. Takamatsu,et al. An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.
[21] J. G. van der Bom,et al. Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.
[22] Y. Sakata,et al. The Factor VIIIa C2 Domain (Residues 2228–2240) Interacts with the Factor IXa Gla Domain in the Factor Xase Complex* , 2009, Journal of Biological Chemistry.
[23] Chien-Nan Lee,et al. Mutation spectrum of 122 hemophilia A families from Taiwanese population by LD-PCR, DHPLC, multiplex PCR and evaluating the clinical application of HRM , 2008, BMC Medical Genetics.
[24] B. Shen,et al. The tertiary structure and domain organization of coagulation factor VIII. , 2008, Blood.
[25] M. Asgharzadeh,et al. Identification of a novel missense mutation in exon 4 of the human factor VIII gene associated with sever hemophilia A patient. , 2007, Pakistan journal of biological sciences : PJBS.
[26] J. Astermark,et al. Polymorphisms in the CTLA‐4 gene and inhibitor development in patients with severe hemophilia A , 2007, Journal of thrombosis and haemostasis : JTH.
[27] T. Lambert,et al. Detection of 95 novel mutations in coagulation factor VIII gene F8 responsible for hemophilia A: results from a single institution , 2006, Human mutation.
[28] J. Astermark,et al. Polymorphisms in the IL-10 but not in the IL-1{beta} and IL-4 genes are associated with inhibitor development in patients with hemophilia A. , 2006 .
[29] B. Dworniczak,et al. Spectrum of molecular defects and mutation detection rate in patients with severe hemophilia A , 2005, Human mutation.
[30] K. Nogami,et al. Mechanisms of Interactions of Factor X and Factor Xa with the Acidic Region in the Factor VIII A1 Domain* , 2004, Journal of Biological Chemistry.
[31] M. Shima,et al. Inversions of the Factor VIII Gene in Japanese Patients with Severe Hemophilia A , 2004, International journal of hematology.
[32] P. Fay. Activation of factor VIII and mechanisms of cofactor action. , 2004, Blood reviews.
[33] C. Rosano,et al. Analysis of 18 novel mutations in the factor VIII gene , 2003, British journal of haematology.
[34] A. Ganguly,et al. High throughput mutation screening of the factor VIII gene (F8C) in hemophilia A: 37 novel mutations and genotype–phenotype correlation , 2002, Human mutation.
[35] A. Thompson,et al. Non-Inversion Factor VIII Mutations in 80 Hemophilia A Families Including 24 with Alloimmune Responses , 2002, Thrombosis and Haemostasis.
[36] A. Thompson,et al. Some factor VIII exon 14 frameshift mutations cause moderately severe haemophilia A , 2001, British journal of haematology.
[37] F. Rosendaal,et al. Definitions in Hemophilia , 2001, Thrombosis and Haemostasis.
[38] P. Lenting,et al. Electron Crystallography of Human Blood Coagulation Factor VIII Bound to Phospholipid Monolayers* , 1999, The Journal of Biological Chemistry.
[39] K. Fujikawa,et al. Structure of the C2 domain of human factor VIII at 1.5 Å resolution , 1999, Nature.
[40] C. Kessler,et al. The genetic basis of inhibitor development in haemophilia A , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.
[41] S. Antonarakis,et al. Partial correction of a severe molecular defect in hemophilia A, because of errors during expression of the factor VIII gene. , 1997, American journal of human genetics.
[42] K. Fukutake,et al. Inversion in Japanese Patients with Hemophilia A , 1995, Thrombosis and Haemostasis.
[43] Stylianos E. Antonarakis,et al. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A , 1993, Nature Genetics.
[44] Masoud Parsania,et al. THE PATIENTS , 1982, California state journal of medicine.
[45] Jay Martin. On Japan , 1978, Current History.
[46] P. Byers. Killing the messenger: new insights into nonsense-mediated mRNA decay. , 2002, The Journal of clinical investigation.
[47] P. Green,et al. Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A. , 2002, Blood.
[48] G. Tagariello,et al. Experience of a single Italian center in genetic counseling for hemophilia: from linkage analysis to molecular diagnosis. , 2000, Haematologica.